Titelia

Holdings of VanEck Biotech ETF

VanEck ETF Trust · 24 declared positions · as of Mar 31, 2026

Original filing · Net assets 371.6M $ · Ten largest lines: 70.9 % of the equity sleeve

Sector breakdown

  • Health care 48.9 %
  • Unattributed 51.1 %

Sector is not declared in Form N-PORT: this is a Titelia classification, decided company by company. The unattributed share is counted as such rather than spread over the others.

Currency breakdown

  • USD 100.0 %

The currency each line is denominated in, as declared. It does not follow the country: a French company listed in the United States is declared in dollars.

Country breakdown

  • US 91.3 %
  • NL 5.3 %
  • DE 2.2 %
  • IE 1.3 %

Shares computed on the equity sleeve, the only part this site carries.

CountryLinesValue (USD)Share
US21339M $91.29 %
NL119.6M $5.28 %
DE18M $2.16 %
IE14.7M $1.27 %

Positions

CompanySharesValue (USD)Weight
Gilead Sciences Inc 390,09254.4M $14.63 %
Amgen Inc 153,58254M $14.54 %
Vertex Pharmaceuticals Inc 67,05329.9M $8.06 %
Regeneron Pharmaceuticals, Inc. 36,13227.9M $7.51 %
Argenx SE 26,85219.6M $5.28 %
Insmed Inc 104,29017.1M $4.59 %
IQVIA Holdings Inc 93,65116M $4.30 %
Alnylam Pharmaceuticals Inc 46,12015.3M $4.11 %
Natera Inc 73,93114.8M $3.98 %
United Therapeutics Corp 23,85614.1M $3.81 %
Biogen Inc 75,44313.8M $3.72 %
BEONE MEDICINES LTD 40,62212.1M $3.25 %
Moderna Inc 226,91011.5M $3.10 %
Revolution Medicines Inc 109,36510.6M $2.86 %
Illumina Inc 75,1339.3M $2.49 %
Incyte Corp 88,7668.4M $2.25 %
BioNTech SE 90,0778M $2.15 %
Neurocrine Biosciences Inc 54,6287.2M $1.94 %
BioMarin Pharmaceutical Inc 91,5975.2M $1.39 %
Bio-Techne Corp 95,8035M $1.35 %
Charles River Laboratories International Inc 27,5394.8M $1.28 %
ICON PLC 42,7184.7M $1.27 %
QIAGEN NV 106,3094.3M $1.15 %
Tempus AI Inc 76,1753.4M $0.93 %